| Biologic Therapy |
1 |
1 |
| Lung Cancer |
0 |
0.99 |
| Otolaryngology |
0 |
0.81 |
| Non-Small Cell Lung Cancer |
0 |
0.76 |
| Breast Cancer |
0 |
0.73 |
| Small Cell Lung Cancer |
0 |
0.54 |
| Cancer |
0 |
0.99 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.5 |
| Pain Management |
0 |
0.46 |
| Antineoplastic Drug |
0 |
0.44 |
| Tyrosine Kinase Inhibitor |
0 |
0.41 |
| Triple Negative Breast Cancer |
0 |
0.38 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.35 |
| HIV Infection |
0 |
0.35 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.33 |
| Tumor |
0 |
0.33 |
| Combination Chemotherapy |
0 |
0.23 |
| Gastrointestinal Stromal Tumor |
0 |
0.21 |
| Patient Safety |
0 |
0.21 |
| Adverse Effects |
0 |
0.2 |
| Chemotherapy |
0 |
0.2 |
| Immunotherapy |
0 |
0.98 |
| Lung |
0 |
0.2 |
| Thrombocytopenia |
0 |
0.19 |
| Constipation |
0 |
0.14 |
| Diarrhea |
0 |
0.14 |
| Myalgia |
0 |
0.14 |
| Neutropenia |
0 |
0.14 |
| Aminotransferase |
0 |
0.13 |
| Anemia |
0 |
0.13 |
| Europe |
0 |
0.13 |
| Fatigue |
0 |
0.13 |
| Pain |
0 |
0.13 |
| Tyrosine Kinase |
0 |
0.13 |
| Esophageal Adenocarcinoma |
0 |
0.12 |
| Upper Respiratory Tract Infection |
0 |
0.09 |
| Adenocarcinoma |
0 |
0.07 |
| Adhesion |
0 |
0.07 |
| Alopecia |
0 |
0.07 |
| Brachial |
0 |
0.07 |
| Breast |
0 |
0.07 |
| Cough |
0 |
0.07 |
| Emesis |
0 |
0.07 |
| Esophagus |
0 |
0.07 |
| Hemorrhage |
0 |
0.07 |
| Hypertension |
0 |
0.07 |
| Leukopenia |
0 |
0.07 |
| Nausea |
0 |
0.07 |
| Platinum |
0 |
0.07 |
| Pneumonia |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Respiratory Tract |
0 |
0.07 |
| Weight Loss |
0 |
0.07 |
| Weight Management |
0 |
0.07 |